Abstract:In calcium nephrolithiasis (CaNL), most calcium kidney stones are identified as calcium oxalate (CaOx) with variable amounts of calcium phosphate (CaP), where CaP is found as the core component. The nucleation of CaP could be the first step of CaP+CaOx (mixed) stone formation. High urinary supersaturation of CaP due to hypercalciuria and an elevated urine pH have been described as the two main factors in the nucleation of CaP crystals. Our previous in vivo findings (in mice) show that transient receptor potential canonical type 3 (TRPC3)-mediated Ca2+ entry triggers a transepithelial Ca2+ flux to regulate proximal tubular (PT) luminal [Ca2+], and TRPC3-knockout (KO; -/-) mice exhibited moderate hypercalciuria and microcrystal formation at the loop of Henle (LOH). Therefore, we utilized TRPC3 KO mice and exposed them to both hypercalciuric [2% calcium gluconate (CaG) treatment] and alkalineuric conditions [0.08% acetazolamide (ACZ) treatment] to generate a CaNL phenotype. Our results revealed a significant CaP and mixed crystal formation in those treated KO mice (KOT) compared to their WT counterparts (WTT). Importantly, prolonged exposure to CaG and ACZ resulted in a further increase in crystal size for both treated groups (WTT and KOT), but the KOT mice crystal sizes were markedly larger. Moreover, kidney tissue sections of the KOT mice displayed a greater CaP and mixed microcrystal formation than the kidney sections of the WTT group, specifically in the outer and inner medullary and calyceal region; thus, a higher degree of calcifications and mixed calcium lithiasis in the kidneys of the KOT group was displayed. In our effort to find the Ca2+ signaling pathophysiology of PT cells, we found that PT cells from both treated groups (WTT and KOT) elicited a larger Ca2+ entry compared to the WT counterparts because of significant inhibition by the store-operated Ca2+ entry (SOCE) inhibitor, Pyr6. In the presence of both SOCE (Pyr6) and ROCE (receptor-operated Ca2+ entry) inhibitors (Pyr10), Ca2+ entry by WTT cells was moderately inhibited, suggesting that the Ca2+ and pH levels exerted sensitivity changes in response to ROCE and SOCE. An assessment of the gene expression profiles in the PT cells of WTT and KOT mice revealed a safeguarding effect of TRPC3 against detrimental processes (calcification, fibrosis, inflammation, and apoptosis) in the presence of higher pH and hypercalciuric conditions in mice. Together, these findings show that compromise in both the ROCE and SOCE mechanisms in the absence of TRPC3 under hypercalciuric plus higher tubular pH conditions results in higher CaP and mixed crystal formation and that TRPC3 is protective against those adverse effects.

High Concentration of Calcium Promotes Mineralization in NRK-52E Cells Via Inhibiting the Expression of Matrix Gla Protein.

Matrix Gla Protein is Involved in Crystal Formation in Kidney of Hyperoxaluric Rats.

Mirna-34A Inhibits Cell Adhesion by Targeting CD44 in Human Renal Epithelial Cells: Implications for Renal Stone Disease

Matrix Gla protein expression in NRK-52E cells exposed to oxalate and calcium oxalate monohydrate crystals.

High Concentration of Calcium Stimulates Calcium Oxalate Crystal Attachment to Rat Tubular Epithelial NRK Cells Through Osteopontin

Does Crystal Deposition in Genetic Hypercalciuric Rat Kidney Tissue Share Similarities With Bone Formation?

[Expression of Matrix Gla Protein and Bone Morphogenetic Protein 2 in Renal Papillary Tissues in Patients with Calcium Oxalate Kidney Stones].

Unexpected Role of Matrix Gla Protein in Osteoclasts: Inhibiting Osteoclast Differentiation and Bone Resorption.

Effect of silencing VDR gene in kidney on renal epithelial calcium transporter proteins and urinary calcium excretion in genetic hypercalciuric stone-forming rats

Matrix Gla Protein Promotes the Bone Formation by Up-Regulating Wnt/β-Catenin Signaling Pathway.

Vitamin K1 Inhibition of Renal Crystal Formation Through Matrix Gla Protein in the Kidney

The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation

Inhibitory Effect of Ginkgo Biloba Extract on Vascular Calcification in Rats with Chronic Kidney Disease by ROS-NF-κB Signaling Pathway

[Effect of Parathyroid Hormone (1-34) on Expression of Matrix Gla Protein and Wnt/β Catenin Signaling Pathways in MG63 Cell Lines].

Effect of Four Different Anti-Osteoporosis Agents on the Expression of Matrix Gla Protein in Primary Osteoblasts of SD Rat

Abnormal expression of Ca2+active transport proteins on basolateral membrane of renal tubule epithelial cells in kidney of rats with genetic hypercalciuric stone-forming and implication

Catechin Prevents the Calcium Oxalate Monohydrate Induced Renal Calcium Crystallization in NRK-52E Cells and the Ethylene Glycol Induced Renal Stone Formation in Rat

An inducible model for medial calcification based on matrix Gla protein deficiency

Indoxyl Sulfate Promotes Osteogenic Differentiation of Vascular Smooth Muscle Cells by Mir-155-5p-dependent Downregulation of Matrix Gla Protein Via ROS/NF-κB Signaling

Mechano-Growth Factor E Peptide Inhibits the Differentiation and Mineralization of Osteoblasts

High Phosphate-Induced Downregulation of PPARγ Contributes to CKD-associated Vascular Calcification